Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antidepressant Treatment Response”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07284667
What this trial is testing

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Who this might be right for
Major Depressive Disorder (MDD)Depressive Disorder, Treatment-Resistant
ACADIA Pharmaceuticals Inc. 153
Post-approval studies (Phase 4)Study completedNCT00759317
What this trial is testing

Physiologic Monitoring of Antidepressant Treatment Response

Who this might be right for
Depression
University of California, Los Angeles 37
Large-scale testing (Phase 3)Study completedNCT00351910
What this trial is testing

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 494
Large-scale testing (Phase 3)Study completedNCT01488071
What this trial is testing

Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 495
Not applicableLooking for participantsNCT06805851
What this trial is testing

Impact of Depression on Thermoregulation

Who this might be right for
DepressionSelective Serotonin Reuptake Inhibitor
Penn State University 64
Testing effectiveness (Phase 2)Study completedNCT02153502
What this trial is testing

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Who this might be right for
Depressive Disorder, Treatment-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 206
Testing effectiveness (Phase 2)Looking for participantsNCT06846320
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Who this might be right for
Generalized Anxiety Disorder (GAD)
AbbVie 315
Large-scale testing (Phase 3)Study completedNCT01157078
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive DisorderDepression
AstraZeneca 319
Large-scale testing (Phase 3)Ended earlyNCT04000009
What this trial is testing

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder
ACADIA Pharmaceuticals Inc. 235
Large-scale testing (Phase 3)Study completedNCT03738215
What this trial is testing

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Who this might be right for
Major Depressive Disorder
AbbVie 759
Large-scale testing (Phase 3)Study completedNCT01942785
What this trial is testing

Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

Who this might be right for
Major Depressive DisorderIrritability
H. Lundbeck A/S 55
Testing effectiveness (Phase 2)Study completedNCT04969510
What this trial is testing

A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Praxis Precision Medicines 110
Large-scale testing (Phase 3)Study completedNCT02141399
What this trial is testing

A Long-Term Safety Study of ALKS 5461

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 1,485
Testing effectiveness (Phase 2)Ended earlyNCT01119430
What this trial is testing

Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder

Who this might be right for
Major Depression
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 50
Large-scale testing (Phase 3)Study completedNCT01353092
What this trial is testing

Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
Hillerod Hospital, Denmark 65
Post-approval studies (Phase 4)Study completedNCT00375843
What this trial is testing

Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication

Who this might be right for
Depression
National Institute of Mental Health (NIMH) 118
Not applicableEnded earlyNCT03872492
What this trial is testing

Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale

Who this might be right for
Depressive Disorder, Major
Ad scientiam 92
Post-approval studies (Phase 4)UnknownNCT02330679
What this trial is testing

Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis

Who this might be right for
Major Depressive Disorder
University of Calgary 61
Testing effectiveness (Phase 2)Ended earlyNCT01288079
What this trial is testing

Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Who this might be right for
Major Depressive Disorder
AstraZeneca 145
Early research (Phase 1)Ended earlyNCT04951609
What this trial is testing

Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 31
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation